Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Resources>White Papers

  White Papers

A Scientific Approach to Good Manufacturing Practices

AMRI
More information
Bile Acids: Beyond Cholesterol Metabolism & Fat Absorption

Pacific Biomarkers
More information
Carbonylation using carbon monoxide: Novasep’s shortcut to complex str

Novasep Inc
More information
Competitive Edge

AMRI
More information
Evolving Intelligence

AMRI
More information
Expedite Development While Ensuring Successful Commercial Outcomes

AMRI
More information
Medical Affairs at the Centre of Life Sciences Innovation

Kinapse
More information
NonClinical Dose Formulation Analysis Method Validation and Sample Ana

SpringerLink
More information
Product Lifecycle Management: Maximizing profit and leveraging innovat

Vetter Pharma International GmbH
More information
<< 1 2 3 >>
showing results 1 to 9 of 19
Scientific News
Alcoholic Hepatitis Treatments Fail to Keep Patients Alive
The study is published in the New England Journal of Medicine.
NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease
Clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events.
No Evidence to Change Current Transfusion Practices for Adults
Study found no difference in the primary clinical measure between complex cardiac surgery patients.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Repurposed Experimental Cancer Drug Restores Brain Function in Mouse Models
NIH-supported research enables clinical trial to explore treatment for most common form of dementia.
Experimental Ebola Vaccine Safe, Prompts Immune Response
Results from US government-sponsored phase 1 trial of VSV vaccine reported.
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
NIH Works to Improve Kidney Health for All
Statement of NIDDK Director Griffin P. Rodgers, M.D., for World Kidney Day 2015.
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters